IONIS-AGT-LRx

N/A

Report date: 2022/08/09 13:54:26
NME

Base Information

Drug NameIONIS-AGT-LRx
Drug Alias NameISISAGTLRxIONISAGTLRxISIS-757456
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAngiotensinogen inhibitors
TargetsAngiotensinogen
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A